VB Spine announced completion of the sale of Stryker’s spinal implants business in Australia and New Zealand.

This builds on the formation of the company on April 1, 2025 following the purchase of Stryker’s U.S. spinal implants business by Viscogliosi Brothers. It also signals the company’s first market entry outside the U.S. and establishes presence in two fast-growing markets.

The company has exclusive access to Stryker’s Mako Spine and Copilot automatic depth stop feature. The partnership creates a foundation for VB Spine’s growth, offering surgeons better precision and improving outcomes.

“From the start, our vision has been simple: put patients first and innovate boldly,” said Marc Viscogliosi, co-CEO of VB Spine, speaking for his brothers and fellow co-CEOs Anthony and John Viscogliosi. “Today we take that vision global. By combining the passion of our family-run culture with LifeHealthcare’s best-in-class surgeon support, we’re opening a new chapter in spine care defined by access, outcomes, and possibility.”

LifeHealthcare is a long-standing distributor for these products and will continue as the exclusive partner.

“We are pleased to announce our long-term collaboration with VB Spine,” said LifeHealthcare CEO Paul Petherbridge. “LifeHealthcare has represented this portfolio since 2010, providing clinicians and patients in Australia and New Zealand with reliable access to spinal instrumentation and implants through our experienced team. Our partnership with VB Spine aligns with our mission for Spine in ANZ: ‘What matters to you drives us.’ We look forward to working with the Viscogliosi brothers and the VB Spine team to offer innovative solutions and valuable education to our clinicians.”